Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Use of deferred consent for severely ill children in a multi-centre phase III trial

Domain:

healthcare
Creator:
KatSasMwaSar
Publisher:
Spr
Host:
Abstract Background Voluntary participation of a subject in research respects a subject's rights, strengthens its ethical conduct, and is formalized by the informed consent process. Clinical trials of life-saving interventions for medical emergencies often necessitate enrolment of patients where prior written individual informed consent is impossible. Although there are regulations and guidelines on protecting subjects in emergency research, these have been criticised for being limited and unnecessarily restrictive. Across Europe and the United States stringent regulations have resulted in a substantial decline of clinical trials involving emergency interventions. Methods We are conducting a trial of fluid resuscitation in children with hypovolaemic shock in six hospitals across three malaria-endemic African countries. The design is pragmatic as children are enrolled on clinical criteria alone and is being conducted in hospitals with facilities typical of many district hospitals across Africa. The trial aims to inform strategy for managing children with febrile illness and features of shock. In order to develop appropriate consent processes for the trial, we conducted a narrative review of current international recommendations for emergency consent. Results Practical or specific guidance was generally sparse or confusing with few examples in the literature to direct our informed consent process. For a sub-group of children who were critically sick or where parents themselves were otherwise too distressed to consider prior written consent, we opted for a modified form of deferred consent. This included verbal assent from guardians at the point of enrolment, with full written consent obtained after stabilising the child. For children who died prior to full written consent, ethical permission was received to waiver full consent. Conclusions In light of the controversy around guidance and regulations in this area we report how and why we have used a modified system of deferred consent in an emergency intervention trial in children. Although approved by all relevant ethics committees and operational in 3 countries in Africa, formal research is now necessary to explore the perceptions and experiences of parents, health workers, researchers and ethics committees of the modified method of deferred consent.

Visit

doi.org

Licenses

http://www.springer.com/tdm

Similar

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.Risk Factors for Mortality in Severely Ill Children Admitted to a Tertiary Referral Hospital in MalawiA standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa feverEffectiveness of a long-lasting insecticide treatment kit (ICON® Maxx) for polyester nets over three years of household use: a WHO phase III trial in TanzaniaDysglycemia in Critically Ill Children Admitted to Jimma Medical Centre, Southwest EthiopiaCommunity acceptance of a novel malaria intervention, Attractive Targeted Sugar Baits, in the Zambia phase III trial

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.

BACKGROUND: There has been much debate about the appropriate statistical methodology for the evalua

Risk Factors for Mortality in Severely Ill Children Admitted to a Tertiary Referral Hospital in Malawi

In low-resource settings, many children are severely ill at arrival to hospital. The risk factors fo

A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever

Background Only one recommendation currently exists for the treatment of Lassa fever (LF), which is

Effectiveness of a long-lasting insecticide treatment kit (ICON® Maxx) for polyester nets over three years of household use: a WHO phase III trial in Tanzania

Abstract Background ICON® Maxx (Syng

Dysglycemia in Critically Ill Children Admitted to Jimma Medical Centre, Southwest Ethiopia

BACKGROUND፡ Abnormal blood glucose level is one of the most frequently encountered problems in child

Community acceptance of a novel malaria intervention, Attractive Targeted Sugar Baits, in the Zambia phase III trial

Background: Community acceptance is an important criterion to assess in community trials, particular